Health and Medical Microalgae Market
Market Insights on Health and Medical Microalgae covering sales outlook, demand forecast & up-to-date key trends
Demand for Microalgae in the Health and Medical Sector Market By Species Type (Spirulina, Chlorella, Dunaliella), Source (Marine Water, Fresh Water), End Use Application (Nutraceuticals and Dietary Supplements, Pharmaceuticals) & Region - Forecast to 2021- 2031
Demand for Microalgae in the Health and Medical Sector Snapshot
As per Future Market Insights (FMI) analysis, the demand for microalgae in the health and medical sector totalled US$ 647.2 Mn in 2021. Surging at 5.8% CAGR the microalgae demand in the health and medical sector is expected to reach US$ 1,133.7 Mn by 2031. Demand rose exceptionally, by 8% in 2021, a trend which will continue through the assessment period.
Amid prevailing competition, manufacturers are putting their efforts towards product launches. This will not only help expanding their portfolio but will pave way for profit maximization. Future Market Insights (FMI) identifies Koninkliijke DSM NV, DIC Corporation, Cyanotech Corporation, Parry Nutraceuticals, Roquette Freres, BGG (Beijing Gingko Group) as leading companies, accounting for g nearly 50-55% of the global demand for microalgae in health and medical sector in 2021.
Let us know your requirement to get
100% FREE customization
Key Points Covered in Demand for Microalgae in the Health and Medical Sector Study
- Market estimates and forecast 2016-2031
- Key drivers and restraints impacting market growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand share and Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Demand for Microalgae in the Health and Medical Sector and How to Navigate
- Recommendation on Key Winning Strategies
2016-2020 Demand for Microalgae in the Health and Medical Sector Outlook in Comparison to 2021-2031 Growth Forecast
Strong growth is on card for global pharmaceutical industry, especially with investment in drug development amplifying consistently. This also points towards favorable demand outlook for microalgae in health and medical sector.
Driven by growing emphasis on natural ingredients in healthcare sector, microalgae application will surge because they are a rich source of nutrients such as β-carotene, astaxanthin, docosahexaenoic acid, EPA, phycobilin pigments and other carotenoids.
Astaxanthin has been studied to show an effective response against atherosclerosis. Consumers are seeking out for clean-label products. Consequently, microalgae consumption in the pharmaceutical industry is set to increase in the foreseeable future. Between 2016 and 2020, the microalgae demand in health and medical sector rose by 4.1%. However, forecast data indicates higher uptake, with demand expected to rise at a CAGR of 5.8% between 2021 and 2031.
Microalgae sales have gained momentum European countries and throughout the U.S. This provides lucrative opportunity for manufacturers to advertise products with trending health claims.
Consumers, particularly millennials, prefer transparency and clean label formulations. Producers of microalgae for health and medical sector application are likely to capitalize on changing consumer preference to carve a niche amid increasing competition.
How is the Prevalence of Lifestyle Diseases Driving Market Growth?
Due to changing lifestyle patterns and hectic schedules, there has been a significant rise in the reported cases of lifestyle-based ailments in recent years. Consumers are taking preventative measures to mitigate the effects of such conditions.
As a result, consumption of joint and bone health supplements is increasing. These supplements also contain additives that control blood pressure, including vitamins and amino acids. The intake of dietary supplements is rapidly rising, which benefits the microalgae market because it is an important ingredient in dietary supplements.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystHow are Rising Healthcare Costs Triggering the Use of Microalgae in the Medical Sector?
Healthcare costs have more than doubled in recent years, owing to increased spending on research and development activities by key players in the healthcare and medical industry. Increasing healthcare costs are influencing consumers to choose health supplements, which provide health benefits including pain relief, minimizing cartilage breakdown, and improving overall health.
According to Research America, medical and health research expenditure in the U.S. increased from US$ 114,386 Mn to US$ 121,825 Mn in 2019 compared to the previous year. As healthcare costs continue to rise, consumers prefer dietary supplements to maintain a healthy lifestyle. The growing popularity of health supplements benefits the microalgae market as it is widely used in health supplements.
Are Vegan Health Ingredients Becoming Mainstream?
As awareness of animal welfare rises, the number of people who are vegan or vegetarian is growing by the day. Several organizations such as NGOs are attempting to minimize animal slaughter. Generation Z and millennials are actively involved in these non-governmental organizations. Furthermore, these non-governmental organizations (NGOs) organize a variety of programs to promote veganism.
Microalgae is high in nutrient content including carotene, astaxanthin, docosahexaenoic acid, EPA, phycobilin pigments, and other carotenoids. Its use in health supplements is increasing because it is vegan and highly nutritious. The growing vegan population is boosting the growth of microalgae in the health and medical sector.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
How is Regulatory Approval for Microalgae Products Fueling Growth?
Microalgae products have been approved for use in the pharmaceutical and nutraceutical industries. Microalgae is a highly nutritious and rich source of various vitamins, which is why, after regulatory approval, the demand for microalgae is increasing from the pharmaceutical and nutraceutical sectors.
What is the Impact of the COVID-19 Crisis on the Demand for Microalgae in the Health Sector?
The nutraceuticals and dietary supplement industries are expected to grow by up to 20% in 2021. The pandemic has encouraged people to consume multivitamins to boost their immunity.
So far, the market has seen significant increases in vitamin C, vitamin E3, vitamin D, and probiotic sales. Thus, the covid-19 crisis will have a moderate impact on demand for microalgae in the health and medical sector.
Country-wise Insights
How Large is the Opportunity for Microalgae Producers in the U.S. Health and Medical Sector?
According to FMI, North America dominates global demand for microalgae in the health and medical sector, and it is anticipated to expand at a high rate during the forecast period. According to recent research, the U.S. is expected to account for nearly 90.0% of the North America market in 2021.
Healthcare consumes well over 10% of the GDP in most developed countries. By the end of 2019, these statistics in the U.S. will be close to 18%. This is not surprising given that the healthcare industry is the largest employer in the country. The U.S. spends far more on healthcare than the rest of the world. Thus, increased spending on healthcare here is creating better opportunities for microalgae in the health and medical sector.
What are the Factors Fuelling Demand for Microalgae in Germany Health and Medical Sector?
Rising demand for microalgae-based health and medical products in Germany will be a significant growth driver. According to the most recent report, the demand in Germany is expected to be worth US$ 29.3 Mn in 2021.
Manufacturers need an extensive network of suppliers and distributors of their products to accomplish this. These manufacturers are also expanding their distribution networks. However, this is primarily done by the industry's leading manufacturers.
How is the Demand for Microalgae in the Health and Medical Sector Set to Fare in Brazil?
Brazil is one of the prominent developing countries in the world. By 2031, it is expected to account for more than 44% of the demand for microalgae in the health and medical sector within Latin America.
Brazil's economy is widely regarded as one of the fastest-growing economies in Latin America. The country has seen positive growth in many aspects of its economy, including consumer spending, investment, and government spending. The healthcare market is the most successful in the country, accounting for approximately 9.7% of the total GDP, creating a conducive environment for growth.
Why is China Dominating the Demand for Microalgae in the Health and Medical Sector?
According to FMI’s analysis, China is estimated to hold nearly 39% of the Asia Pacific value share in the year 2021. Carotenoids are becoming more popular in China owing to the large animal feed industry and an increase in demand for health supplements.
Furthermore, the highly established pharmaceuticals industry, which uses carotenoids and related product types to meet market demand, is another factor contributing to the growth of microalgae in the health and medical sector.
Older adults make up a large proportion of the population in China, and they are the most frequent users of predictive and preventive medicine. These health issues including vision loss, are frequently associated with vitamin deficiency. So, according to FMI, as the demand for carotenoids rises globally, it will have a positive impact on the growth of the microalgae market in China.
Why is the Demand for Microalgae in the Health and Medical Sector Rising in Japan?
Japan is a dominant country in the Asia Pacific. Japan accounted for more than 32% of the market share in 2021. In Japan, most consumers do not get enough antioxidants from their diet because they do not eat enough vegetables, fish and fruits.
Microalgae is a powerful antioxidant that works to supplement dietary formulations. It allows manufacturers to differentiate their products and give their antioxidant products a competitive advantage. The popularity of dietary supplements with antioxidant claims is growing in Japan.
Category-wise Insights
Which Species of Microalgae Accounted for Maximum Share in the Global Market?
Spirulina contains anti-inflammatory, antioxidant, and immune-stimulating compounds such as phycocyanin, polysaccharides and phenolic. Furthermore, spirulina processing products are used in nutraceuticals and dietary supplements, pharmaceutics, and medicine.
Thus, spirulina is estimated to account for a value of US$ 251.8 Mn in 2021 and also projected to witness a lucrative growth rate of a CAGR 4.1% during the forecast period.
Which Source Accounted for Maximum Share in Demand for Microalgae in the Health and Medical Sector?
Freshwater sources of microalgae are estimated to account for nearly 80% of the market share in 2021, which is expected to witness a growth rate of CAGR 5.3% over the forecast period to reach a value of US$ 860.1 Mn in 2031.
Easy availability of raw materials, extensive man-made cultivation operations and cost benefits are key factors aiding growth.
Which Application Accounts for the Maximum Microalgae Demand in Health and Medical Sector?
The nutraceuticals and dietary supplements segment accounted for a maximum share of nearly 84% in 2021, which is also expected to witness significant growth rate of CAGR 5.3% over the forecast period.
Microalgae are gaining interest as a source of nutraceuticals and dietary supplements because they can produce a variety of biological molecules and compounds, which are beneficial to the animal and human health development.
Competitive Landscape
Manufacturers of microalgae-based products can benefit from increasing the frequency of product launches to better reach consumers and meet the growing demand for microalgae products in the health and medical sector. New market participants can formulate diversified microalgae formats and incorporate them into products such as nutraceuticals to attract a larger consumer base.
- In September 2019, one of the astaxanthin-based product manufacturers, Atacama Bio Natural Products, headquartered in Chile, launched NatAxtinTM, which is derived from microalgae.
- In April 2021, Sophie’s Bionutrients announced the launch of new plant-based food range made from microalgae to provide an alternative to meat products.
- Euglena Co. announced a collaboration with Next Meats Co. Ltd., for the cultivation of Euglena and Chlorella microalgae species for healthcare and biofuel applications.
Scope of Report
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
USD Million for Value |
|
Key Countries Covered |
US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa |
|
Key Segments Covered |
Species Type, Source, End Use Application, and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
|
Customization and Pricing |
Available upon Request |
Demand for Microalgae in the Health and Medical Sector by Category
By Species Type:
- Spirulina
- Chlorella
- Dunaliella
- Aphanizomenon
- Haematococcus
- Crypthecodinium
- Schizochytrium
- Euglena
- Nannochloropsis
- Nostoc
- Phaedactylum
- Others
By Source:
- Marine Water
- Fresh Water
By End Use Application:
- Nutraceuticals and Dietary Supplements
- Pharmaceuticals
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa (MEA)
Frequently Asked Questions
The demand for microalgae in the health and medical sector is set to grow at a 5.8% CAGR between 2021 and 2031.
The demand for microalgae in the health and medical sector is estimated at US$ 647.2 Mn in 2021.
The demand for microalgae in the health and medical sector hit 46,125 DW tons in 2021.
The demand for microalgae in the health and medical sector rose at 4.1% CAGR from 2016 to 2020.
Koninkliijke DSM NV, DIC Corporation, Cyanotech Corporation, Parry Nutraceuticals, Roquette Freres, and BGG (Beijing Gingko Group) are the leading players accounting for 50 to 55% value share.
The demand for microalgae in the health and medical sector in North America is set to grow at a 4.9% CAGR.
The demand for microalgae in the health and medical sector in Europe will grow at a 5.5% CAGR.
The demand for microalgae in the health and medical sector in China and Japan accounts for 36.8% and 32% value share respectively.
The demand for microalgae in the health and medical sector reflected an 8% y-o-y growth from 2020 to 2021.
Investments into product Innovation, clean label trends, rising health awareness associated with microalgae and growing demand of carotenoids are key trends influencing demand for microalgae in the health and medical sector.
1. Market Overview
1.1. Market Coverage / Taxonomy
1.2. Market Definition / Scope / Limitations
2. Scenario Assessment of the Impact of COVID-19 on Demand for Microalgae in Health & Medical Sector
2.1. Global Demand for Microalgae in Health & Medical Sector Forecast Scenario Comparison of Annual Growth Rates for short Term (2021-2023) and Long Term (2024-2031)
2.1.1. Optimistic Scenario
2.1.1.1. China
2.1.1.2. US
2.1.1.3. Euro Zone
2.1.1.4. Asia Pacific
2.1.1.5. Rest of the World
2.1.2. Likely Scenario
2.1.2.1. China
2.1.2.2. US
2.1.2.3. Euro Zone
2.1.2.4. Asia Pacific
2.1.2.5. Rest of the World
2.1.3. Pessimistic Scenario
2.1.3.1. China
2.1.3.2. US
2.1.3.3. Euro Zone
2.1.3.4. Asia Pacific
2.1.3.5. Rest of the World
2.2. Key Factors Impacting the Market
2.3. Case Studies- Lessons from the companies that survived & thrived in the last recession
2.4. Customers will change some behaviors permanently- accelerating prior trends; bold action now can set you up for success through the downturn and beyond
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Market Background
4.1. Policy Developments and Regulatory Scenario
4.2. Macro-Economic Factors
4.2.1. Global GDP Growth Outlook
4.2.2. Global Industry Value Added
4.3. Forecast Factors - Relevance & Impact
4.3.1. Global Chemicals Industry Outlook
4.3.2. Global Healthcare Industry Outlook
4.3.3. Global Food & Beverage Industry Outlook
4.3.4. Global Urbanization Growth Outlook
4.4. Value Chain Analysis
4.4.1. Raw Material Suppliers
4.4.2. Product Manufacturers
4.4.3. Distributors/Suppliers
4.4.4. End Users
4.5. Market Dynamics
4.5.1. Drivers
4.5.2. Restraints
4.6. Opportunity
4.7. Value Chain Analysis
4.7.1. Supply Side Participants and their Roles
4.7.1.1. Producers
4.7.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
4.7.1.3. Wholesalers and Distributors
4.7.2. Profit Margin Analysis
4.7.2.1. Traders/ Agents/ Brokers
4.7.2.2. Wholesalers and Distributors
4.7.2.3. Retailers
4.7.3. Operating Margins By Region
4.7.4. Notes on Value Added at Each Node in the Value Chain
4.8. Key Regulations
4.8.1. Federal Food & Cosmetics Act
4.8.2. China Food & Safety Authority
4.8.3. State Food and Drug Administration (SFDA)
4.8.4. Foods for Specified Health Uses
4.8.5. FSSAI
4.8.6. Food Packaging Claims
4.8.7. Labelling and Claims
4.8.8. Import/Export Regulations
5. Global Demand for Microalgae in Health & Medical Sector - Pricing Analysis
5.1. Regional Pricing Analysis (US$/DW Tons) By Species Type, 2021
5.2. Pricing Break-up
5.2.1. Manufacturer Level Pricing
5.2.2. Distributor Level Pricing
5.3. Global Average Pricing Analysis Benchmark
6. Global Demand for Microalgae in Health & Medical Sector 2021-2031 and Forecast, 2021-2031
6.1. Historical Market Volume (DW Tons) Analysis, 2015-2019
6.2. Current and Future Market Volume (DW Tons) Projections, 2021-2031
6.3. Y-o-Y Growth Trend Analysis
7. Global Demand for Microalgae in Health & Medical Sector 2021-2031 and Forecast 2021-2031, By Species Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Thousands) and Volume Analysis By Species Type, 2016 - 2020
7.3. Current and Future Market Size (US$ Thousands) and Volume Analysis and Forecast By Species Type, 2021 - 2031
7.3.1. Spirulina
7.3.2. Chlorella
7.3.3. Dunaliella
7.3.4. Aphanizomenon
7.3.5. Haematococcus
7.3.6. Crypthecodinium
7.3.7. Schizochytrium
7.3.8. Euglena
7.3.9. Nannochloropsis
7.3.10. Nostoc
7.3.11. Phaedactylum
7.3.12. Others
7.4. Market Attractiveness Analysis By Species Type
8. Global Demand for Microalgae in Health & Medical Sector 2016-2020 and Forecast 2021-2031, By Source
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Thousands) and Volume Analysis By Source, 2016 - 2020
8.3. Current and Future Market Size (US$ Thousands) and Volume Analysis and Forecast By Source, 2021 – 2031
8.3.1. Marine Water
8.3.2. Fresh Water
8.4. Market Attractiveness Analysis By Source
9. Global Demand for Microalgae in Health & Medical Sector 2021-2031 and Forecast 2021-2031, By End Use Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Thousands) and Volume Analysis By End Use Application , 2016 - 2020
9.3. Current and Future Market Size (US$ Thousands) and Volume Analysis and Forecast By End Use Application , 2021 - 2031
9.3.1. Nutraceuticals & Dietary Supplements
9.3.2. Pharmaceuticals
9.4. Market Attractiveness Analysis
10. Global Demand for Microalgae in Health & Medical Sector 2021-2031 and Forecast 2021-2031, By Region
10.1. Introduction
10.2. Historical Market Size (US$ Thousands) and Volume Analysis By Region, 2016 - 2020
10.3. Current Market Size (US$ Thousands) and Volume Analysis and Forecast By Region, 2021 - 2031
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Demand for Microalgae in Health & Medical Sector 2021-2031and Forecast 2021-2031
11.1. Historical Market Size (US$ Thousands) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
11.2. Market Size (US$ Thousands) and Volume Forecast By Market Taxonomy, 2021 - 2031
11.2.1. By Country
11.2.1.1. U.S.
11.2.1.2. Canada
11.2.2. By Species Type
11.2.3. By Source
11.2.4. By End Use Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Species Type
11.3.3. By Source
11.3.4. By End Use Application
11.4. Key Takeaways
12. Latin America Demand for Microalgae in Health & Medical Sector 2021-2031 and Forecast 2021-2031
12.1. Historical Market Size (US$ Thousands) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
12.2. Market Size (US$ Thousands) and Volume Forecast By Market Taxonomy, 2021 - 2031
12.2.1. By Country
12.2.1.1. Brazil
12.2.1.2. Mexico
12.2.1.3. Chile
12.2.1.4. Peru
12.2.1.5. Rest of Latin America
12.2.2. By Species Type
12.2.3. By Source
12.2.4. By End Use Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Species Type
12.3.3. By Source
12.3.4. By End Use Application
12.4. Key Takeaways
13. Europe Demand for Microalgae in Health & Medical Sector 2021-2031 and Forecast 2021-2031
13.1. Historical Market Size (US$ Thousands) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
13.2. Market Size (US$ Thousands) and Volume Forecast By Market Taxonomy, 2021 - 2031
13.2.1. By Country
13.2.1.1. Germany
13.2.1.2. Italy
13.2.1.3. France
13.2.1.4. U.K.
13.2.1.5. Spain
13.2.1.6. BENELUX
13.2.1.7. Nordic
13.2.1.8. Russia
13.2.1.9. Poland
13.2.1.10. Rest of Europe
13.2.2. By Species Type
13.2.3. By Source
13.2.4. By End Use Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Species Type
13.3.3. By Source
13.3.4. By End Use Application
13.4. Key Takeaways
14. Asia Pacific Demand for Microalgae in Health & Medical Sector 2021-2031 and Forecast 2021-2031
14.1. Historical Market Size (US$ Thousands) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
14.2. Market Size (US$ Thousands) and Volume Forecast By Market Taxonomy, 2021 - 2031
14.2.1. By Country
14.2.1.1. India
14.2.1.2. China
14.2.1.3. Japan
14.2.1.4. ASEAN Countries
14.2.1.5. Oceania
14.2.1.6. Rest of Pacific
14.2.2. By Species Type
14.2.3. By Source
14.2.4. By End Use Application
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Species Type
14.3.3. By Source
14.3.4. By End Use Application
14.4. Key Takeaways
15. Middle East and Africa Demand for Microalgae in Health & Medical Sector 2021-2031 and Forecast 2021-2031
15.1. Historical Market Size (US$ Thousands) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
15.2. Market Size (US$ Thousands) and Volume Forecast By Market Taxonomy, 2021 - 2031
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. North Africa
15.2.1.3. South Africa
15.2.1.4. Central Africa
15.2.1.5. Rest of Middle East and Africa
15.2.2. By Species Type
15.2.3. By Source
15.2.4. By End Use Application
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Species Type
15.3.3. By Source
15.3.4. By End Use Application
15.4. Key Takeaways
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Species Type
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. DIC Corporation
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments (Product/Channel/Region)
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Cyanotech Corporation
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments (Product/Channel/Region)
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Koninkliijke DSM NV
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments (Product/Channel/Region)
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Roquette Frères
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments (Product/Channel/Region)
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. BASF SE
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments (Product/Channel/Region)
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Fuji Chemical Industries Co., Ltd.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments (Product/Channel/Region)
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Parry Nutraceuticals
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments (Product/Channel/Region)
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. BGG (Beijing Gingko Group)
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments (Product/Channel/Region)
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. KDI Ingredients
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments (Product/Channel/Region)
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Sinoway Industrial Co., ltd.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments (Product/Channel/Region)
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. INNOBIO Corporation Limited
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments (Product/Channel/Region)
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
17.1.12. Yunnan Alphy Biotech Co., Ltd
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments (Product/Channel/Region)
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.12.5.2. Product Strategy
17.1.12.5.3. Channel Strategy
17.1.13. Algaecan Biotech Ltd.
17.1.13.1. Overview
17.1.13.2. Product Portfolio
17.1.13.3. Profitability by Market Segments (Product/Channel/Region)
17.1.13.4. Sales Footprint
17.1.13.5. Strategy Overview
17.1.13.5.1. Marketing Strategy
17.1.13.5.2. Product Strategy
17.1.13.5.3. Channel Strategy
17.1.14. Algatechnologies Ltd.
17.1.14.1. Overview
17.1.14.2. Product Portfolio
17.1.14.3. Profitability by Market Segments (Product/Channel/Region)
17.1.14.4. Sales Footprint
17.1.14.5. Strategy Overview
17.1.14.5.1. Marketing Strategy
17.1.14.5.2. Product Strategy
17.1.14.5.3. Channel Strategy
17.1.15. Cardax, Inc.
17.1.15.1. Overview
17.1.15.2. Product Portfolio
17.1.15.3. Profitability by Market Segments (Product/Channel/Region)
17.1.15.4. Sales Footprint
17.1.15.5. Strategy Overview
17.1.15.5.1. Marketing Strategy
17.1.15.5.2. Product Strategy
17.1.15.5.3. Channel Strategy
17.1.16. Igene Biotechnology, Inc.
17.1.16.1. Overview
17.1.16.2. Product Portfolio
17.1.16.3. Profitability by Market Segments (Product/Channel/Region)
17.1.16.4. Sales Footprint
17.1.16.5. Strategy Overview
17.1.16.5.1. Marketing Strategy
17.1.16.5.2. Product Strategy
17.1.16.5.3. Channel Strategy
17.1.17. Fenchem Biotek Ltd.
17.1.17.1. Overview
17.1.17.2. Product Portfolio
17.1.17.3. Profitability by Market Segments (Product/Channel/Region)
17.1.17.4. Sales Footprint
17.1.17.5. Strategy Overview
17.1.17.5.1. Marketing Strategy
17.1.17.5.2. Product Strategy
17.1.17.5.3. Channel Strategy
17.1.18. AstaReal Inc.
17.1.18.1. Overview
17.1.18.2. Product Portfolio
17.1.18.3. Profitability by Market Segments (Product/Channel/Region)
17.1.18.4. Sales Footprint
17.1.18.5. Strategy Overview
17.1.18.5.1. Marketing Strategy
17.1.18.5.2. Product Strategy
17.1.18.5.3. Channel Strategy
17.1.19. Valensa International
17.1.19.1. Overview
17.1.19.2. Product Portfolio
17.1.19.3. Profitability by Market Segments (Product/Channel/Region)
17.1.19.4. Sales Footprint
17.1.19.5. Strategy Overview
17.1.19.5.1. Marketing Strategy
17.1.19.5.2. Product Strategy
17.1.19.5.3. Channel Strategy
17.1.20. Kunming Biogenic Co., Ltd.
17.1.20.1. Overview
17.1.20.2. Product Portfolio
17.1.20.3. Profitability by Market Segments (Product/Channel/Region)
17.1.20.4. Sales Footprint
17.1.20.5. Strategy Overview
17.1.20.5.1. Marketing Strategy
17.1.20.5.2. Product Strategy
17.1.20.5.3. Channel Strategy
18. Assumptions and Acronyms Used
19. Research Methodology
Let us know your requirement to get
100% FREE customization
Table 1: Global Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type, 2016–2020
Table 2: Global Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type,2021–2031
Table 3: Global Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type, 2016–2020
Table 4: Global Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type,2021–2031
Table 5: Global Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source, 2016–2020
Table 6: Global Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source,2021–2031
Table 7: Global Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source, 2016–2020
Table 8: Global Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source,2021–2031
Table 9: Global Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications, 2016–2020
Table 10: Global Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications,2021–2031
Table 11: Global Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications, 2016–2020
Table 12: Global Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications,2021–2031
Table 13: Global Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Region, 2016–2020
Table 14: Global Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Region,2021–2031
Table 15: Global Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Region, 2016–2020
Table 16: Global Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Region,2021–2031
Table 17: North America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type, 2016–2020
Table 18: North America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type,2021–2031
Table 19: North America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type, 2016–2020
Table 20: North America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type,2021–2031
Table 21: North America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source, 2016–2020
Table 22: North America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source,2021–2031
Table 23: North America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source, 2016–2020
Table 24: North America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source,2021–2031
Table 25: North America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications, 2016–2020
Table 26: North America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications,2021–2031
Table 27: North America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications, 2016–2020
Table 28: North America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications,2021–2031
Table 29: North America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country, 2016–2020
Table 30: North America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country,2021–2031
Table 31: North America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country, 2016–2020
Table 32: North America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country,2021–2031
Table 33: Latin America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type, 2016–2020
Table 34: Latin America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type,2021–2031
Table 35: Latin America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type, 2016–2020
Table 36: Latin America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type,2021–2031
Table 37: Latin America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source, 2016–2020
Table 38: Latin America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source,2021–2031
Table 39: Latin America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source, 2016–2020
Table 40: Latin America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source,2021–2031
Table 41: Latin America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications, 2016–2020
Table 42: Latin America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications,2021–2031
Table 43: Latin America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications, 2016–2020
Table 44: Latin America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications,2021–2031
Table 45: Latin America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country, 2016–2020
Table 46: Latin America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country,2021–2031
Table 47: Latin America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country, 2016–2020
Table 48: Latin America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country,2021–2031
Table 49: Europe Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type, 2016–2020
Table 50: Europe Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type,2021–2031
Table 51: Europe Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type, 2016–2020
Table 52: Europe Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type,2021–2031
Table 53: Europe Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source, 2016–2020
Table 54: Europe Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source,2021–2031
Table 55: Europe Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source, 2016–2020
Table 56: Europe Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source,2021–2031
Table 57: Europe Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications, 2016–2020
Table 58: Europe Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications,2021–2031
Table 59: Europe Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications, 2016–2020
Table 60: Europe Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications,2021–2031
Table 61: Europe Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country, 2016–2020
Table 62: Europe Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country,2021–2031
Table 63: Europe Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country, 2016–2020
Table 64: Europe Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country,2021–2031
Table 65: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type, 2016–2020
Table 66: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type,2021–2031
Table 67: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type, 2016–2020
Table 68: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type,2021–2031
Table 69: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source, 2016–2020
Table 70: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source,2021–2031
Table 71: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source, 2016–2020
Table 72: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source,2021–2031
Table 73: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications, 2016–2020
Table 74: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications,2021–2031
Table 75: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications, 2016–2020
Table 76: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications,2021–2031
Table 77: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country, 2016–2020
Table 78: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country,2021–2031
Table 79: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country, 2016–2020
Table 80: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country,2021–2031
Table 81: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type, 2016–2020
Table 82: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type,2021–2031
Table 83: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type, 2016–2020
Table 84: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type,2021–2031
Table 85: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source, 2016–2020
Table 86: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source,2021–2031
Table 87: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source, 2016–2020
Table 88: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source,2021–2031
Table 89: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications, 2016–2020
Table 90: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications,2021–2031
Table 91: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications, 2016–2020
Table 92: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications,2021–2031
Table 93: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country, 2016–2020
Table 94: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country,2021–2031
Table 95: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country, 2016–2020
Table 96: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country,2021–2031
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystFigure 1: Global Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type, 2016–2020
Figure 2: Global Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type,2021–2031
Figure 3: Global Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type, 2016–2020
Figure 4: Global Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type,2021–2031
Figure 5: Global Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source, 2016–2020
Figure 6: Global Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source,2021–2031
Figure 7: Global Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source, 2016–2020
Figure 8: Global Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source,2021–2031
Figure 9: Global Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications, 2016–2020
Figure 10: Global Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications,2021–2031
Figure 11: Global Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications, 2016–2020
Figure 12: Global Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications,2021–2031
Figure 13: Global Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Region, 2016–2020
Figure 14: Global Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Region,2021–2031
Figure 15: Global Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Region, 2016–2020
Figure 16: Global Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Region,2021–2031
Figure 17: North America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type, 2016–2020
Figure 18: North America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type,2021–2031
Figure 19: North America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type, 2016–2020
Figure 20: North America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type,2021–2031
Figure 21: North America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source, 2016–2020
Figure 22: North America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source,2021–2031
Figure 23: North America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source, 2016–2020
Figure 24: North America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source,2021–2031
Figure 25: North America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications, 2016–2020
Figure 26: North America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications,2021–2031
Figure 27: North America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications, 2016–2020
Figure 28: North America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications,2021–2031
Figure 29: North America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country, 2016–2020
Figure 30: North America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country,2021–2031
Figure 31: North America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country, 2016–2020
Figure 32: North America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country,2021–2031
Figure 33: Latin America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type, 2016–2020
Figure 34: Latin America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type,2021–2031
Figure 35: Latin America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type, 2016–2020
Figure 36: Latin America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type,2021–2031
Figure 37: Latin America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source, 2016–2020
Figure 38: Latin America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source,2021–2031
Figure 39: Latin America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source, 2016–2020
Figure 40: Latin America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source,2021–2031
Figure 41: Latin America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications, 2016–2020
Figure 42: Latin America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications,2021–2031
Figure 43: Latin America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications, 2016–2020
Figure 44: Latin America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications,2021–2031
Figure 45: Latin America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country, 2016–2020
Figure 46: Latin America Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country,2021–2031
Figure 47: Latin America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country, 2016–2020
Figure 48: Latin America Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country,2021–2031
Figure 49: Europe Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type, 2016–2020
Figure 50: Europe Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type,2021–2031
Figure 51: Europe Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type, 2016–2020
Figure 52: Europe Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type,2021–2031
Figure 53: Europe Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source, 2016–2020
Figure 54: Europe Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source,2021–2031
Figure 55: Europe Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source, 2016–2020
Figure 56: Europe Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source,2021–2031
Figure 57: Europe Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications, 2016–2020
Figure 58: Europe Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications,2021–2031
Figure 59: Europe Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications, 2016–2020
Figure 60: Europe Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications,2021–2031
Figure 61: Europe Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country, 2016–2020
Figure 62: Europe Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country,2021–2031
Figure 63: Europe Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country, 2016–2020
Figure 64: Europe Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country,2021–2031
Figure 65: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type, 2016–2020
Figure 66: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type,2021–2031
Figure 67: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type, 2016–2020
Figure 68: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type,2021–2031
Figure 69: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source, 2016–2020
Figure 70: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source,2021–2031
Figure 71: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source, 2016–2020
Figure 72: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source,2021–2031
Figure 73: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications, 2016–2020
Figure 74: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications,2021–2031
Figure 75: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications, 2016–2020
Figure 76: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications,2021–2031
Figure 77: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country, 2016–2020
Figure 78: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country,2021–2031
Figure 79: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country, 2016–2020
Figure 80: Asia Pacific Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country,2021–2031
Figure 81: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type, 2016–2020
Figure 82: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Species Type,2021–2031
Figure 83: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type, 2016–2020
Figure 84: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Species Type,2021–2031
Figure 85: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source, 2016–2020
Figure 86: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Source,2021–2031
Figure 87: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source, 2016–2020
Figure 88: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Source,2021–2031
Figure 89: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications, 2016–2020
Figure 90: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by End Use Applications,2021–2031
Figure 91: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications, 2016–2020
Figure 92: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by End Use Applications,2021–2031
Figure 93: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country, 2016–2020
Figure 94: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Value (US$ Thousands) and Forecast by Country,2021–2031
Figure 95: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country, 2016–2020
Figure 96: Middle East & Africa Demand for Microalgae in Health & Medical Sector Market Volume (DW Tons) and Forecast by Country,2021–2031
Need specific information?
Request CustomizationExplore Food and Beverage Insights
View Reports
